Cargando…

Overexpression of CCDC69 activates p14(ARF)/MDM2/p53 pathway and confers cisplatin sensitivity

OBJECTIVES: The aim of the study is to explore the relationship between CCDC69 expression and resistance of ovarian cancer cells to cisplatin and reveal the underlying mechanism. METHODS: One hundred thirty five ovarian cancer patients with intact chemo-response information from The Cancer Genome At...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Long, Zhou, Fang, Chen, Cui, Wang, Chi Chiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334460/ https://www.ncbi.nlm.nih.gov/pubmed/30651135 http://dx.doi.org/10.1186/s13048-019-0479-3

Ejemplares similares

Pinning Control for the p53-Mdm2 Network Dynamics Regulated by p14ARF
por: Suarez, Oscar J., et al.
Publicado: (2020)

Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung
por: Xue, Qi, et al.
Publicado: (2001)

LRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2017)

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2018)

MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells
por: Vivo, Maria, et al.
Publicado: (2015)

Genetic Variation in MDM2 and p14 (ARF) and Susceptibility to Salivary Gland Carcinoma
por: Jin, Lei, et al.
Publicado: (2012)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Hypermethylation of the 5′ CpG island of the p14(ARF) flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression
por: Nyiraneza, Christine, et al.
Publicado: (2012)

Decreased Mdm2 Expression Inhibits Tumor Development and Extends Survival Independent of Arf and Dependent on p53
por: Eischen, Christine M., et al.
Publicado: (2012)

Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators
por: Schlott, T, et al.
Publicado: (2002)

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53
por: Walter, R F H, et al.
Publicado: (2015)

Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection
por: Li, Jing, et al.
Publicado: (2016)

It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
por: Kung, Che-Pei, et al.
Publicado: (2022)

Retraction Note: Hypermethylation of the 5′ CpG island of the p14(ARF) flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression
por: Nyiraneza, Christine, et al.
Publicado: (2023)

Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function
por: Kowalczyk, Dominika, et al.
Publicado: (2022)

Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
por: Klimovich, Boris, et al.
Publicado: (2019)

MDM2 Overexpression with Alteration of the p53 Protein and Gene Status in Oral Carcinogenesis
por: Li, Xiao‐Jun, et al.
Publicado: (2000)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex
por: Huang, Xinping, et al.
Publicado: (2023)

Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression
por: Wang, J, et al.
Publicado: (2016)

PRL-3 promotes breast cancer progression by downregulating p14(ARF)-mediated p53 expression
por: Xie, Hua, et al.
Publicado: (2018)

P14(ARF): The Absence that Makes the Difference
por: Cilluffo, Danilo, et al.
Publicado: (2020)

Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer
por: Amir, Sumaira, et al.
Publicado: (2013)

Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations
por: Yu, Qiong, et al.
Publicado: (2014)

Aberrant expression of CCDC69 in breast cancer and its clinicopathologic significance
por: Li, Jinjiao, et al.
Publicado: (2021)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

p14(ARF )expression in invasive breast cancers and ductal carcinoma in situ – relationships to p53 and Hdm2
por: Vestey, SB, et al.
Publicado: (2004)

p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes
por: Kashuba, Elena, et al.
Publicado: (2003)

Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14(ARF)-Mediated Sustained p53 Activation
por: Tomicic, Maja T., et al.
Publicado: (2021)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levels
por: Wang, Ying, et al.
Publicado: (2001)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Progressive silencing of p14ARF in oesophageal adenocarcinoma
por: Huang, Yinghui, et al.
Publicado: (2009)

The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
por: Wagner, Kay-Dietrich, et al.
Publicado: (2022)

Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers
por: Gudikote, Jayanthi P., et al.
Publicado: (2021)

Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
por: Xiaofang, Liu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mgaov62s03jovuj4iaejm7kqri